Literature DB >> 3178479

Risk of infection after open fracture of the arm or leg.

E P Dellinger1, S D Miller, M J Wertz, M Grypma, B Droppert, P A Anderson.   

Abstract

Two hundred forty consecutive patients admitted for operative treatment of an open fracture of the arm or leg were followed up prospectively for the development of fracture infection. The independent risk of fracture infection was increased in patients with grade IIIB or IIIC fractures, internal or external fixation, lower-leg fracture, any blood transfusion, or injuries resulting from motorcycle accidents or motor vehicle-pedestrian accidents. By stepwise multivariate logistic regression, the most significant risk factors were the grade of the fracture, internal or external fixation, and fractures of the lower leg. These risk factors all represent local wound characteristics, and we conclude that the most important actions by the surgeon to prevent infection involve local wound care. There was no relation between the timing of antibiotic administration or duration of antibiotic therapy and infection risk.

Entities:  

Mesh:

Year:  1988        PMID: 3178479     DOI: 10.1001/archsurg.1988.01400350034004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  36 in total

1.  Culture-independent pilot study of microbiota colonizing open fractures and association with severity, mechanism, location, and complication from presentation to early outpatient follow-up.

Authors:  Geoffrey D Hannigan; Brendan P Hodkinson; Kelly McGinnis; Amanda S Tyldsley; Jason B Anari; Annamarie D Horan; Elizabeth A Grice; Samir Mehta
Journal:  J Orthop Res       Date:  2014-01-03       Impact factor: 3.494

2.  Reamer-Irrigator-Aspirator bone graft harvesting for treatment of segmental bone loss: analysis of defect volume as independent risk factor for failure.

Authors:  W J Metsemakers; G Claes; P J Terryn; A Belmans; H Hoekstra; S Nijs
Journal:  Eur J Trauma Emerg Surg       Date:  2017-07-25       Impact factor: 3.693

3.  Injury patterns and outcomes of open fractures of the proximal ulna do not differ from closed fractures.

Authors:  Paul H Yi; Alexander A Weening; Sangmin R Shin; Khalil I Hussein; Paul Tornetta; Andrew Jawa
Journal:  Clin Orthop Relat Res       Date:  2014-07       Impact factor: 4.176

4.  Standardized practice is associated with low rate of surgical site infection in orthopaedic trauma.

Authors:  Daniel Schmitt; Megan Rodts; Benjamin Davis; Hobie Summers; Mitchell Bernstein; William Lack
Journal:  J Clin Orthop Trauma       Date:  2018-12-30

5.  What is the rate of methicillin-resistant Staphylococcus aureus and Gram-negative infections in open fractures?

Authors:  Antonia F Chen; Verena M Schreiber; Wesley Washington; Nalini Rao; Andrew R Evans
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

6.  Amputation versus functional reconstruction in the management of complex hind foot injuries caused by land-mine explosions: a long-term retrospective comparison.

Authors:  Bahtiyar Demiralp; Tolga Ege; Ozkan Kose; Yuksel Yurttas; Mustafa Basbozkurt
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-10-25

Review 7.  Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery.

Authors:  Kenneth L Urish; James E Cassat
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 8.  Transfusion-associated bacterial sepsis.

Authors:  S J Wagner; L I Friedman; R Y Dodd
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

9.  Immediate versus delayed intramedullary nailing for open fractures of the tibial shaft: a multivariate analysis of factors affecting deep infection and fracture healing.

Authors:  Kazuhiko Yokoyama; Moritoshi Itoman; Masataka Uchino; Kensuke Fukushima; Hiroshi Nitta; Yoshiaki Kojima
Journal:  Indian J Orthop       Date:  2008-10       Impact factor: 1.251

10.  Treatment principles in the management of open fractures.

Authors:  William W Cross; Marc F Swiontkowski
Journal:  Indian J Orthop       Date:  2008-10       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.